Social determinants of health and treatment decisions in head and neck cancer

Shehan, Jennifer N.; Alwani, Tooba; LeClair, Jessica; Mahoney, Taylor F.; Agarwal, Pratima; Chaudhry, Salil T.; Wang, Judy J.; Noordzij, J. Pieter; Tracy, Lauren F.; Edwards, Heather; Grillone, Gregory A.; Salama, Andrew; Jalisi, Scharukh; Devaiah, Anand K.

doi:10.1002/hed.26931

Cited by 7 publications

(5 citation statements)

References 32 publications

(37 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Malignant tumors of the head and neck disproportionately affect low-income communities: patients with low SES are at increased risk of developing HNC and have a poorer prognosis . These results emphasize the intersectionality of social drivers of health: low HL in patients with HNC may further exacerbate preexisting health disparities, specifically in vulnerable patients …”

Section: Discussionmentioning

confidence: 98%

“…[51][52][53] These results emphasize the intersectionality of social drivers of health: low HL in patients with HNC may further exacerbate preexisting health disparities, specifically in vulnerable patients. 34,51,54,55 Alternatively, it has been suggested that low HL may be a potential mediator of health disparities in patients with low SES and among certain ethnic and racial populations. Several studies have shown that low HL mediates the relationship between race or low SES and health outcomes and medication adherence.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Readability of Patient Education Materials in Head and Neck Cancer

Armache,

Assi,

et al. 2024

JAMA Otolaryngol Head Neck Surg

View full text Add to dashboard Cite

ImportancePatient education materials (PEMs) can promote patient engagement, satisfaction, and treatment adherence. The American Medical Association recommends that PEMs be developed for a sixth-grade or lower reading level. Health literacy (HL) refers to an individual’s ability to seek, understand, and use health information to make appropriate decisions regarding their health. Patients with suboptimal HL may not be able to understand or act on health information and are at risk for adverse health outcomes.ObjectiveTo assess the readability of PEMs on head and neck cancer (HNC) and to evaluate HL among patients with HNC.Evidence ReviewA systematic review of the literature was performed by searching Cochrane, PubMed, and Scopus for peer-reviewed studies published from 1995 to 2024 using the keywords head and neck cancer, readability, health literacy, and related synonyms. Full-text studies in English that evaluated readability and/or HL measures were included. Readability assessments included the Flesch-Kincaid Grade Level (FKGL grade, 0-20, with higher grades indicating greater reading difficulty) and Flesch Reading Ease (FRE score, 1-100, with higher scores indicating easier readability), among others. Reviews, conference materials, opinion letters, and guidelines were excluded. Study quality was assessed using the Appraisal Tool for Cross-Sectional Studies.FindingsOf the 3235 studies identified, 17 studies assessing the readability of 1124 HNC PEMs produced by professional societies, hospitals, and others were included. The mean FKGL grade ranged from 8.8 to 14.8; none of the studies reported a mean FKGL of grade 6 or lower. Eight studies assessed HL and found inadequate HL prevalence ranging from 11.9% to 47.0%.Conclusions and RelevanceThese findings indicate that more than one-third of patients with HNC demonstrate inadequate HL, yet none of the PEMs assessed were developed for a sixth grade or lower reading level, as recommended by the American Medical Association. This incongruence highlights the need to address the readability of HNC PEMs to improve patient understanding of the disease and to mitigate potential barriers to shared decision-making for patients with HNC. It is crucial to acknowledge the responsibility of health care professionals to produce and promote more effective PEMs to dismantle the potentially preventable literacy barriers.

show abstract

Section: Discussionmentioning

confidence: 98%

Section: Discussionmentioning

confidence: 99%

Readability of Patient Education Materials in Head and Neck Cancer

Armache,

Assi,

et al. 2024

JAMA Otolaryngol Head Neck Surg

View full text Add to dashboard Cite

show abstract

“…Existing research indicates that non-English speakers are less likely to follow multidisciplinary team treatment recommendations [ 7 ] resulting in poorer outcomes [ 8 ]. National Institute for Health and Care Excellence (NICE) guidelines [CG138] for improving the experience of care for people using adult NHS services' state that healthcare providers have a responsibility to ensure all patients have access to interpretation services when this is required [ 9 ].…”

Section: Introductionmentioning

confidence: 99%

Interpretation services used for non-English language speaking patients with head and neck cancer: Findings from a tertiary London cancer centre

Chartkul,

Cook,

Govender

2024

Oral Oncology Reports

View full text Add to dashboard Cite

“…SCC accounts for 90–95% of all head and neck cancer cases ( 8 ). Other less common types include salivary gland tumors, lymphomas and sarcomas ( 9 ).…”

Section: Introductionmentioning

confidence: 99%

Expanding the role of combined immunochemotherapy and immunoradiotherapy in the management of head and neck cancer (Review)

Wei,

Lan,

Qiu

et al. 2023

Oncol Lett

View full text Add to dashboard Cite

Immunotherapy has become one of the most promising approaches in tumor therapy, and there are numerous associated clinical trials in China. As an immunosuppressive tumor, head and neck squamous cell carcinoma (HNSCC) carries a high mutation burden, making immune checkpoint inhibitors promising candidates in this field due to their unique mechanism of action. The present review outlines a comprehensive multidisciplinary cancer treatment approach and elaborates on how combining immunochemotherapy and immunoradiotherapy guidelines could enhance clinical efficacy in patients with HNSCC. Furthermore, the present review explores the immunology of HNSCC, current immunotherapeutic strategies to enhance antitumor activity, ongoing clinical trials and the future direction of the current immune landscape in HNSCC. Advanced-stage HNSCC presents with a poor prognosis, low survival rates and minimal improvement in patient survival trends over time. Understanding the potential of immunotherapy and ways to combine it with surgery, chemotherapy and radiotherapy confers good prospects for the management of human papillomavirus (HPV)-positive HNSCC, as well as other HPV-positive malignancies. Understanding the immune system and its effect on HNSCC progression and metastasis will help to uncover novel biomarkers for the selection of patients and to enhance the efficacy of treatments. Further research on why current immune checkpoint inhibitors and targeted drugs are only effective for some patients in the clinic is needed; therefore, further research is required to improve the overall survival of affected patients.

show abstract

Social determinants of health and treatment decisions in head and neck cancer

Cited by 7 publications

References 32 publications

Readability of Patient Education Materials in Head and Neck Cancer

Readability of Patient Education Materials in Head and Neck Cancer

Interpretation services used for non-English language speaking patients with head and neck cancer: Findings from a tertiary London cancer centre

Expanding the role of combined immunochemotherapy and immunoradiotherapy in the management of head and neck cancer (Review)

Contact Info

Product

Resources

About